Capital Fund Management (CFM)’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-198,855
| Closed | -$982K | – | 604 |
|
|
2023
Q1 | $982K | Sell |
198,855
-96,926
| -33% | -$479K | ﹤0.01% | 442 |
|
|
2022
Q4 | $1.86M | Buy |
295,781
+230,979
| +356% | +$1.45M | 0.01% | 369 |
|
|
2022
Q3 | $700K | Sell |
64,802
-44,239
| -41% | -$478K | 0.01% | 461 |
|
|
2022
Q2 | $1.24M | Buy |
109,041
+4,688
| +4% | +$53.4K | 0.01% | 429 |
|
|
2022
Q1 | $951K | Buy |
+104,353
| New | +$951K | 0.01% | 477 |
|
|
2020
Q2 | – | Sell |
-10,342
| Closed | -$201K | – | 516 |
|
|
2020
Q1 | $201K | Buy |
+10,342
| New | +$201K | ﹤0.01% | 760 |
|